We are happy to inform you that we are certified providers in CooperVision’s Brilliant Futures Myopia Management Program. The cornerstone of this comprehensive approach to myopia management in pediatric patients is the MiSight 1 day contact lens – the first and only contact lens approved by the FDA to slow myopia progression in children, aged 8-12 at the initiation of treatment.
The correlation between increasing myopia and potentially vision-threatening complications later in life is well established and is a growing concern for both eye care practitioners and parents worldwide. Here in the United States, the rate of myopia occurrence has increased from 25% to 42% over the last two generations. This is due to a combination of genetic and lifestyle factors.
MiSight 1 day contact lenses have been shown in a multi-year clinical trial to reduce the average rate of progression of myopia by 59%, which means that the relative risk of a myopia-associated pathology can be significantly reduced.4 This convenient, daily disposable contact lens is well-accepted by children and does not affect their daily activities. It is designed to be worn for ten or more hours per day, six or more days per week to get the maximum treatment effect.
We are very excited to offer the Brilliant Futures Myopia Management Program to our patients and we hope that you will join us in our efforts to combat pediatric myopia for a brighter tomorrow. If you would like any further information on managing myopia in children, please don’t hesitate to get in touch with me.